Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Pharmacist only' medicines|
|Citation:||Australian and New Zealand Journal of Public Health, 1999; 23(6):661-662|
|Publisher:||PUBLIC HEALTH ASSOC AUSTRALIA INC|
|Abstract:||While there is a global trend to switch medicines from prescription to non-prescription status, Australia has created a unique schedule of 'pharmacist only medicines' (POM). Such medicines may provide consumers with greater choice and control of health care decisions. However, the impact of these actions has not been evaluated. Public health concerns including the appropriate use of medicines, awareness and equity of access to POM, and access to information on POM are discussed using antifungal vaginal products as an example. The National Medicines Policy advocates a partnership approach to achieve improved health outcomes by the quality use of medicines, however currently no data on POM are available. Recommendations include changes to legislation, public health data collection and the provision of quality information including pharmaceutical and non-pharmaceutical interventions.|
|Keywords:||Humans; Risk Assessment; Public Health; Health Care Reform; Drug Industry; Drug Costs; Policy Making; South Australia; Patient Education as Topic; Nonprescription Drugs|
|Appears in Collections:||Public Health publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.